Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions
Open accessThe DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Abstract
Interactions between viruses and the host antibody immune response are critical in the development and control of disease, and antibodies are also known to interfere with the efficacy of viral vector-based gene delivery. The adeno-associated viruses (AAVs) being developed as vectors for corrective human gene delivery have shown promise in clinical trials, but preexisting antibodies are detrimental to successful outcomes. However, the antigenic epitopes on AAV capsids remain poorly characterized. Cryo-electron microscopy and three-dimensional image reconstruction were used to define the locations of epitopes to which monoclonal fragment antibodies (Fabs) against AAV1, AAV2, AAV5, and AAV6 bind. Pseudoatomic modeling showed that, in each serotype, Fabs bound to a limited number of sites near the protrusions surrounding the 3-fold axes of the T=1 icosahedral capsids. For the closely related AAV1 and AAV6, a common Fab exhibited substoichiometric binding, with one Fab bound, on average, between two of the three protrusions as a consequence of steric crowding. The other AAV Fabs saturated the capsid and bound to the walls of all 60 protrusions, with the footprint for the AAV5 antibody extending toward the 5-fold axis. The angle of incidence for each bound Fab on the AAVs varied and resulted in significant differences in how much of each viral capsid surface was occluded beyond the Fab footprints. The AAV-antibody interactions showed a common set of footprints that overlapped some known receptor-binding sites and transduction determinants, thus suggesting potential mechanisms for virus neutralization by the antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“VR-VIII is part of an AAV2 antigenic epitope, and the difference is consistent with rAAV2.7m8’s escape from a known AAV2 monoclonal antibody, C37-B.”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Gurda et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“This observation is consistent with the positioning of the peptide insert above at the epitope mapped for C37-B to VR-VIII using cryo-EM of the AAV2-C37-B complex (Fig. 8B) (Gurda et al., 2013).”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Gurda et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The rAAV2.7m8 insertion modified the C37-B antibody binding site (Gurda et al., 2013) creating an escape variant.”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Gurda et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828 · cited 7×
“The fit-in-map function in Chimera was used to compare each AAV:Fab cryo-reconstruction to the corresponding map of the AAV:Fab model for quantitative assessment of the Fab docking.”
MethodInfluentialCoot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 5×
“docked models in the program COOT (75), the absolute scale of each map”
InfluentialFeatures and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984 · cited 5×
“(WAM) model of the 4E4 Fab, the PDBePISA application (84)”
BackgroundMethodInfluentialCryo-electron microscopy of vitrified specimens
Dubochet, J., Adrian, M., Chang, J.-J., Homo, J.-C., Lepault, J., McDowall, A. W., & Schultz, P. (1988) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500004297 · Cited by 2,389 · cited 1×
“5 l) of AAV:Fab complexes were vitrified using standard rapid freeze-plunging procedures (64, 65).”
MethodManno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490 · cited 1×
“Each AAV serotype has a distinct ability to transduce cells and tissues of different hosts when the same transgene is packaged, indicating that the capsid itself dictates these differences (27, 37).”
BackgroundSummerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Self-citationCryo-electron microscopy of viruses
Adrian, M., Dubochet, J., Lepault, J., & McDowall, A. W. (1984) · Nature · doi:10.1038/308032a0 · Cited by 1,342 · cited 1×
“5 l) of AAV:Fab complexes were vitrified using standard rapid freeze-plunging procedures (64, 65).”
Method
Research works printed but not linked: 2
- 18. Chapman MS, Agbandje-McKenna M. 2006. Atomic structures of viral particles, p 107–123 In Kerr JR, Cotmore SF, Bloom ME, Linden RL, Parrish CR. (ed), Parvoviruses. Edward Arnold, Ltd., New York, NY [Google Scholar]
- 19. Agbandje-McKenna M, Chapman MS. 2006. Corrleating structure with function in the viral capsid, p 125–139 In Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR. (ed), Parvoviruses. Edward Arnold, Ltd., New York, NY [Google Scholar]
Cited by
Items 101–130 of 130
Giovanni Cardone, A., Yan, X., Sinkovits, R. S., Tang, J., & Baker, T. S. (2013) · Journal of Structural Biology · doi:10.1016/j.jsb.2013.07.007 · Cited by 6
Self-citationGrueso, E., Sánchez-Martínez, C., Calvo-López, T., de Miguel, F. J., Blanco-Menéndez, N., Fernandez-Estévez, M., Elizalde, M., Sanchez, J., Kourani, O., Martin, D. L., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00798-19 · Cited by 6
Tomczyk, M., Kraszewska, I., Mąka, R., Waligórska, A., Dulak, J., & Jaźwa, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240691 · Cited by 5
“Binding of neutralizing antibodies (nAbs), targeting viral epitopes critical for cellular entry or vector disassembly, to the capsid limits infectivity of the viral vector and may have a profound effect on gene transfer efficiency [23, 24].”
BackgroundViral Vector Technologies and Strategies: Improving on Nature
Croze, R. H., Kotterman, M. A., Burns, C. H., Schmitt, C. E., Quezada, M., Schaffer, D. V., Kirn, D. H., & Francis, P. J. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000361 · Cited by 5
Adeno-associated Virus as a Mammalian DNA Vector
Salganik, M., Hirsch, M. L., & Samulski, R. J. (2015) · ASM Press eBooks · doi:10.1128/9781555819217.ch37 · Cited by 5
Self-citationBrun, M. J., Song, K., Kang, B., Lueck, C., Chen, W., Thatcher, K., Gao, E., Koch, W. J., Lincoln, J., Rajan, S., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.058 · Cited by 4
Self-citationZhu, L., Xu, K., Ding, Y., Liu, K., Liu, J., Hou, Z., Niu, R., Yang, N., Qin, H., Hu, B., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70127 · Cited by 3
Xiao, S., Zhu, X., Zheng, M., Jiang, D., Zheng, C., Cheng, X., Wang, S., You, G., Chen, S., & Chen, S. (2025) · Veterinary Research · doi:10.1186/s13567-025-01625-6 · Cited by 1
“…virus serotype 5 (AAV5), a Parvoviridae family member with ~ 59% VP3 amino acid similarity and structural homology to waterfowl parvovi-ruses, indicates that VP3 residues 65, 296, and 301 correspond to AAV5 VP residues 258, 486, and 491, contact residues for monoclonal antibody 3C5 (IgG3) [42].”
MADCAP: isolation of novel nAb-naïve AAV capsids from metagenomic data
Lyashenko, E., Torregrosa, T., Ysasi, A. B., Wu, J. T., Bu, J., Hennessy, M., Na, Y., Ryan, M. J., Takar, M., Manek, R., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00630-26 · Cited by 1
“…variants of the capsid surface do not appear to be distinguishing specifically between neutralizing and non-neutralizing antibodies, possibly hinting that antibody affinity, as opposed to just binding pose, may be highly influential in distinguishing binding and neutralizing antibodies (41, 42).”
Cai, Z., Liu, Y., Zhao, L., Li, X., Zhang, B., Tang, Y., Zhou, T., Zheng, Z., Li, A., Wei, J., et al. (2026) · The Open Biotechnology Journal · doi:10.2174/0118740707483472261006060307 · Cited by 1
Adeno-Associated Virus Vectors for Gene Therapy
Mietzsch, M. (2014) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10246 · Cited by 1
Intracellular fate of AAV particles in human Dendritic Cell and impact on Gene Transfer
Rossi, A. (2016) · theses.fr (ABES) · doi:10.70675/4518d4eazdbd8z4f46z96e2zf87942913c70
Design of Caspase and MMP-Activatable Adeno-Associated Virus Vectors and Their In Vivo Application
Brun, M. J. (2020) · Rice Research Repository (Rice University)
Improved Strategies for Directed Evolution of Adeno-Associated Virus Gene Therapy Vectors
Ojala, D. S. (2017) · eScholarship (California Digital Library)
Conboy, I. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733450908.793553930
Silveria, M. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94095
Li, L., Qin, R., Liu, Y., Tseng, Y.-S., Zhang, W., Yu, L., Mietzsch, M., Zou, X., Liu, H., Lu, G., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012260
“…AAV6 Participates in heparin binding of AAV6 [31] K493 or D495 /AAV1 and AAV6 Within the footprint of monoclonal antibody 4E4 on the AAV1 capsid [32] E 548 /AAV2 or A 551 /AAV8 Within the footprint of monoclonal antibody A20 on the AAV2 capsid [33] Q594/AAV8 Within the interacting domain of…”
BackgroundSelf-citationShaban, A. H., El‐Gebaly, A. M., Sayed, A. O., Abdullatef, A. M., Ahmed, A. M., El-Beheady, A., Mostafa, D. M. M., Eid, E. M. A., El-Kady, H. A., Masoud, H. H., et al. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106660
Hope Unlocked: Gene Therapy with Viral Vectors and Gene Editing
Thiaville, J. J., Dias, M. S., Kato, S. E. M., Basak, S., Rengarajan, S., Silva, H. P., Rivas, N., & D’Costa, S. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-81787-8_5
Pal, P., Naskar, R., Paul, B., Oruganti, S., & Chakraborty, S. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01279
Li, W. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/p8kc-az55
Exploration of genes and identification of evolutionary evidence in adeno-associated viruses
Lee, C., Min, J., Lim, S., Park, A., Kwak, S., Hwang, S., Park, S., Jang, Y., Cha, S.-Y., Cho, S.-G., et al. (2026) · The Journal of Microbiology · doi:10.71150/jm.2511016
“Furthermore, X-ray crystallography and cryo-EM revealed the structural details of these nine variable regions, which typically present as surface-exposed loops or protrusions on the capsid (Gurda et al., 2013; Lerch et al., 2010).”
Development of safe and efficient aav vectors for retinal gene therapy
Khabou, H. (2018) · theses.fr (ABES) · doi:10.70675/aa896663z9772z4d87z9bd1z247af1f0e3f1
The immunogenicity and safety of adenoviral-based vaccines
Gardner, J. (2026) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001167
Environmental and developmental factors shape anti-AAV immunity in pigs
Iroanya, G. I., Raju, I., Boosani, C. S., Subramanyam, P. N., Byrne, A. K., Wells, K. D., & Green, J. A. (2026) · Gene Therapy · doi:10.1038/s41434-026-00625-1
Metadata
- Authors
- Gurda, B. L., DiMattia, M. A., Miller, E. B., Bennett, A., McKenna, R., Weichert, W. S., Nelson, C. D., Chen, W.-J., Muzyczka, N., Olson, N. H., Sinkovits, R. S., Chiorini, J. A., Zolotutkhin, S., Kozyreva, O. G., Samulski, R. J., Baker, T. S., Parrish, C. R., & Agbandje-McKenna, M.
- Affiliations
- University of Florida (US)
- Cornell University (US)
- University of California San Diego (US)
- National Institutes of Health (US)
- University of North Carolina at Chapel Hill (US)
- Deptartment of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida, USA
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2013-08-15
- Volume
- 87
- Issue
- 16
- Pages
- 9111-9124
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3754064
- OpenAlex
- W2171084404
- Cited by
- 127
- References
- 104
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 15 · 2020: 14 · 2019: 15 · 2018: 13 · 2017: 8 · 2016: 5 · 2015: 9 · 2014: 9 · 2013: 4
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (4r37gm033050-27)
- University of California, San Diego
- National Heart, Lung, and Blood Institute (P01HL112761)
- National Institute of General Medical Sciences (R37GM-033050, R37 GM-33050, R01GM082946)
- National Institute of Allergy and Infectious Diseases (R01AI072176, R21AI072341)
- National Center for Research Resources (S10RR020016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- adeno-associated virus, AAV capsid, antibody epitopes, AAV serotypes, AAV1, AAV2, AAV5, AAV6, steric crowding, virus neutralization, gene therapy vectors, receptor binding sites
- MeSH terms
- Dependovirus, Antibodies, Monoclonal, Antibodies, Viral, Epitopes, Binding Sites, Capsid, Humans, Models, Molecular, Protein Binding, Cryoelectron Microscopy, Imaging, Three-Dimensional, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.